Utreloxastat (PTC857) is a compound used for the research of the disorders including alpha-synucleinopathies, tauopathies, Amyotrophic lateral sclerosis (ALS), traumatic brain injury, and ischemic-reperfusion related injuries (patent WO2020081879A2, example
Molecular Weight:
276.41
Purity:
99.69
CAS Number:
[1213269-96-5]
Formula:
C18H28O2
Target:
alpha-synuclein
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted